Cannava & NOC Pharma
Global Partners in CBD Medical Solutions
Cannava is a leading pharmaceutical company in Argentina, dedicated to cultivating, producing, and distributing high-quality CBD-based medicines in partnership with the Argentine health system. Recognized for its advanced research and development capabilities, Cannava works closely with public health institutions to provide safe, effective, and affordable cannabis-based therapies that improve the lives of thousands of patients.
Leveraging years of experience and a commitment to pharmaceutical-grade quality, Cannava has established itself as a trusted name in the Latin American medical cannabis industry. Through compliance with international standards, including EU-GMP (Good Manufacturing Practices) and GACP (Good Agricultural and Collection Practices), Cannava ensures that every product meets the highest safety, purity, and consistency levels.
As Cannava expands its reach beyond Latin America, NOC Pharma has become its exclusive partner for the European market. This partnership aims to bring Cannava’s trusted product lines to Europe, offering patients and healthcare providers access to high-quality CBD medicines tailored to meet the stringent regulatory requirements of the region.
CBD 5 - CBD 10 - CBD 20
Isolate Line
This line uses an extract of flowers as an active pharmaceutical ingredient of medical cannabis that is purified with pharma technology, achieving isolate the CBD molecule at 100% levels and ensuring the non- detectability of other cannabinoids, terpenes, and flavonoids.
CBD 10 PLUS - AVATARA VEX -CBD FORTE
Concentrated Extracts
This line uses as an active pharmaceutical ingredient a concentrated medical cannabis flower extract that is formulated to expand, enhance, and increase the therapeutic benefits of medical cannabis according to the patient's response to their treatment indicated by the medical professional.
Register Now / Sign In
CANNAVA CBD 20
STABILITY STUDIES
Following ICH standards and validated methods Accelerated stability up to 6 40 months + 2 C / 75 + 5% RH Long-term stability up to 12 months 25 + 2 C / 60 + 5 % RH
QUALITY ASSURANCE
COA analytical certificate according to European and Argentinian pharmacopeia standards per batch for quality control and standardization of pharmaceutical formulation.
THERAPEUTIC USE
High-dose titration for various pathologies – refractory epilepsy, inflammatory bowel disease (Crohn's disease and ulcerative colitis), osteoarthritis, rheumatoid arthritis, fibromyalgia and osteoporosis.
Isolate Line
Therapeutic-medicinal product from isolates of CBD.
Free of heavy metals, pesticides and pollutants. No TACC.
Power: 20% CBD (200mg/ml).
Dosage form: oral solution.
Active ingredient: cannabidiol.
Recipients: pharma grade sesame oil, lemon flavoring.
Quality: GACP and GMP certifications.
Packaging: in amber PET dropper bottle with injection nitrogen.
Presentations: 10 and 30 ml.
CANNAVA CBD 10
Isolate Line
STABILITY STUDIES
Following ICH standards and validated methods Accelerated stability up to 6 40 months + 2 C / 75 + 5% RH Long-term stability up to 12 months 25 + 2 C / 60 + 5 % RH
QUALITY ASSURANCE
COA analytical certificate according to European and Argentinian pharmacopeia standards per batch for quality control and standardization of pharmaceutical formulation.
THERAPEUTIC USE
High-dose titration for various pathologies – refractory epilepsy, inflammatory bowel disease (Crohn's disease and ulcerative colitis), osteoarthritis, rheumatoid arthritis, fibromyalgia and osteoporosis.
Therapeutic-medicinal product from isolates of CBD.
Free of heavy metals, pesticides and pollutants. No TACC.
Power: 10% CBD (100mg/ml).
Dosage form: oral solution.
Active ingredient: cannabidiol.
Recipients: pharma grade sesame oil, lemon flavoring.
Quality: GACP and GMP certifications.
Packaging: in amber PET dropper bottle with injection nitrogen.
Presentations: 10 and 30 ml.
CANNAVA CBD 5
Isolate Line
STABILITY STUDIES
Following ICH standards and validated methods Accelerated stability up to 6 40 months + 2 C / 75 + 5% RH Long-term stability up to 12 months 25 + 2 C / 60 + 5 % RH
QUALITY ASSURANCE
COA analytical certificate according to European and Argentinian pharmacopeia standards per batch for quality control and standardization of pharmaceutical formulation.
THERAPEUTIC USE
High-dose titration for various pathologies – refractory epilepsy, inflammatory bowel disease (Crohn's disease and ulcerative colitis), osteoarthritis, rheumatoid arthritis, fibromyalgia and osteoporosis.
Therapeutic-medicinal product from isolates of CBD.
Free of heavy metals, pesticides and pollutants. No TACC.
Power: 5% CBD (50mg/ml).
Dosage form: oral solution.
Active ingredient: cannabidiol.
Recipients: pharma grade sesame oil, lemon flavoring.
Quality: GACP and GMP certifications.
Packaging: in amber PET dropper bottle with injection nitrogen.
Presentations: 10 and 30 ml.
CANNAVA CBD 10 Plus
Concentrated Extract Line
STABILITY STUDIES
Following ICH standards and validated methods Accelerated stability up to 6 40 months + 2 C / 75 + 5% RH Long-term stability up to 12 months 25 + 2 C / 60 + 5 % RH
QUALITY ASSURANCE
COA analytical certificate according to European and Argentinian pharmacopeia standards per batch for quality control and standardization of pharmaceutical formulation.
THERAPEUTIC USE
Enhance and/or prolong benefits Therapeutics of CBD in Pathologies of refractory epilepsy, disease intestinal disease (intestinal disease) Crohn's disease and ulcerative colitis), osteoarthritis, rheumatoid arthritis, Bromyalgia, osteoporosis, bruxism and primary chronic pain, neuropathic, post-herpetic
Therapeutic-medicinal product from isolates of CBD.
Free of heavy metals, pesticides and pollutants. No TACC.
Power: 10 % CBD (100 mg/ml) 0,3 % THC (3 mg/ml).
Dosage form: oral solution.
Active ingredient: cannabidiol.
Recipients: pharma grade sesame oil, lemon flavoring.
Quality: GACP and GMP certifications.
Packaging: in amber PET dropper bottle with injection nitrogen.
Presentations: 10 and 30 ml.
CANNAVA CBD FORTE
Concentrated Extract Line
STABILITY STUDIES
Following ICH standards and validated methods Accelerated stability up to 6 40 months + 2 C / 75 + 5% RH Long-term stability up to 12 months 25 + 2 C / 60 + 5 % RH
QUALITY ASSURANCE
COA analytical certificate according to European and Argentinian pharmacopeia standards per batch for quality control and standardization of pharmaceutical formulation.
THERAPEUTIC USE
Dose titration for pain chronic (3 months or +) non-acute neuropathic, musculoskeletal, cancer, post-surgical, postherpetic, visceral and headaches/migraines.
Therapeutic-medicinal product from isolates of CBD.
Free of heavy metals, pesticides and pollutants. No TACC.
Power: 20 % CBD (200 mg/ml) 2,7 % THC (27 mg/ml).
Dosage form: oral solution.
Active ingredient: cannabidiol.
Recipients: pharma grade sesame oil, lemon flavoring.
Quality: GACP and GMP certifications.
Packaging: in amber PET dropper bottle with injection nitrogen.
Presentations: 10 and 30 ml.
CANNAVA AVATARA VEX
Concentrated Extract Line
STABILITY STUDIES
Following ICH standards and validated methods Accelerated stability up to 6 40 months + 2 C / 75 + 5% RH Long-term stability up to 12 months 25 + 2 C / 60 + 5 % RH
QUALITY ASSURANCE
COA analytical certificate according to European and Argentinian pharmacopeia standards per batch for quality control and standardization of pharmaceutical formulation.
THERAPEUTIC USE
Chronic neuropathic pain, provoked for advanced cancer, neuralgia of the trigeminal disorders temporomandibly, spasms intense muscle stiffness, stiffness that doesn't responds to standard treatments, Parkinson's, cachexia, nausea, and vomiting in cancer and HIV or not respond to standard treatment.
Therapeutic-medicinal product from isolates of CBD.
Free of heavy metals, pesticides and pollutants. No TACC.
Power: 2,5 % CBD (25 mg/ml) 2,7 % THC (27 mg/ml).
Dosage form: oral solution.
Active ingredient: cannabidiol.
Recipients: pharma grade sesame oil, lemon flavoring.
Quality: GACP and GMP certifications.
Packaging: in amber PET dropper bottle with injection nitrogen.
Presentations: 10 and 30 ml.